Who is sponsoring NCT00626301?

NCT00626301 is sponsored by The HIV Netherlands Australia Thailand Research Collaboration.

What condition does NCT00626301 study?

NCT00626301 studies HIV Infections.

What is the status of NCT00626301?

NCT00626301 is currently COMPLETED.

Last reviewed 2015-03-25 · How we verify

Simplifying Antiretroviral Treatment in Virally Suppressed Children by Switching From Double Boosted Protease Inhibitors to Lopinavir/Ritonavir Monotherapy

NCT00626301 Phase 4 COMPLETED

The purpose of this study is to evaluate the efficacy (clinical, immunological, virological outcome), pharmacokinetics and safety of lopinavir/ritonavir (LPV/r) monotherapy maintenance in Thai children after viral load suppression with double boosted protease inhibitors (PIs).

Details

Lead sponsor	The HIV Netherlands Australia Thailand Research Collaboration
Phase	Phase 4
Status	COMPLETED
Enrolment	40
Start date	2007-11
Completion	2009-09

Conditions

HIV Infections

Interventions

LPV/r

Primary outcomes

To evaluate efficacy (clinical, immunological, virological outcome), pharmacokinetics and safety of LPV/r monotherapy maintenance in Thai children after viral load suppression with double boosted PIs — 48 weeks

Countries

Thailand